Houston – September 22, 2026 -- Nutex Health Inc. (NASDAQ: NUTX) has secured approval to dual-list its common stock on Nasdaq Texas, with trading set to begin on or about Sept. 23, 2026.
Nutex Health keeps primary listing on Nasdaq Global Market while adding Texas venue
The company's shares will continue trading under the ticker "NUTX" on the Nasdaq Global Market. Shares will remain fully fungible across both venues, and the dual listing requires no action from existing stockholders.
Company operates 28 hospital facilities across 12 states under physician-led model
Nutex Health runs a healthcare services and operations business built around a primary care-centric, risk-bearing physician network. The Houston-based firm filed a registration statement on Form 8-A with the U.S. Securities and Exchange Commission under Section 12(b) of the Securities Exchange Act of 1934 in connection with the listing.
CEO cites regional investor visibility as driver behind Texas listing
"With our senior leadership and corporate headquarters firmly anchored in the Houston metropolitan area, this expands our visibility among regional institutional investors while maintaining the national and international presence of our primary Nasdaq market," said Tom Vo, M.D., MBA, Chairman and CEO of Nutex Health Inc.